Search

Back to Leadership

Elaine J. Heron

  • Director, Vaxart, Inc.
  • Director, Visgenx, Inc.
  • Director, Watershed Medical, Inc.

Committee(s):

  • Audit
  • Corporate Governance and Nominating
  • Science and Technology

LinkedIn

Elaine J. Heron, Ph.D. joined our Board in July 2002. From February 2009 to October 2015, Dr. Heron served as Chair and CEO of Amplyx Pharmaceuticals, Inc., a private drug development company acquired by Pfizer, Inc. in April 2021.

Dr. Heron currently serves on the boards of Vaxart, Inc., a public clinical-stage biotechnology company, Visgenx, Inc., a private early-stage therapeutics company, and Watershed Medical, Inc., a private early-stage therapeutics company. Dr. Heron is also an advisor to Kyto Technology and Life Science, Inc. (OTCQB:KBPH) and Cairn Biosciences, Inc. From July 2001 to October 2008, Dr. Heron was Chair and CEO of Labcyte Inc., a private biotechnology company. Before joining Labcyte Inc., Dr. Heron spent six years in positions of increasing responsibility at the Applied Biosystems Group of Applera Corporation, a biotechnology company, including the position of General Manager and Vice President of Sales and Marketing.

Dr. Heron holds a B.S. in Chemistry with highest distinction and a Ph.D. in Analytical Biochemistry from Purdue University and an M.B.A. from Pepperdine University.